Potential Alzheimer's disease therapeutic nano-platform: Discovery of amyloid-beta plaque disaggregating agent and brain-targeted delivery system using porous silicon nanoparticles
Authors:
Open Access
- 1 June 2023
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 24, 497-506
Abstract
There has been a lot of basic and clinical research on Alzheimer's disease (AD) over the last 100 years, but its mechanisms and treatments have not been fully clarified. Despite some controversies, the amyloid-beta hypothesis is one of the most widely accepted causes of AD. In this study, we disclose a new amyloid-beta plaque disaggregating agent and an AD brain-targeted delivery system using porous silicon nanoparticles (pSiNPs) as a therapeutic nano-platform to overcome AD. We hypothesized that the negatively charged sulfonic acid functional group could disaggregate plaques and construct a chemical library. As a result of the in vitro assay of amyloid plaques and library screening, we confirmed that 6-amino-2-naphthalenesulfonic acid (ANA) showed the highest efficacy for plaque disaggregation as a hit compound. To confirm the targeted delivery of ANA to the AD brain, a nano-platform was created using porous silicon nanoparticles (pSiNPs) with ANA loaded into the pore of pSiNPs and biotin-polyethylene glycol (PEG) surface functionalization. The resulting nano-formulation, named Biotin-CaCl2-ANA-pSiNPs (BCAP), delivered a large amount of ANA to the AD brain and ameliorated memory impairment of the AD mouse model through the disaggregation of amyloid plaques in the brain. This study presents a new bioactive small molecule for amyloid plaque disaggregation and its promising therapeutic nano-platform for AD brain-targeted delivery.Keywords
Funding Information
- Ministry of Education (2018-R1A6A1A03025124)
- Ministry of Science, ICT and Future Planning (2022-R1F1A1069954)
- Ministry of Health and Welfare (HI21C0239)
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Ministry of Science ICT and Future Planning (2021-M3A9I5030523, 2022-M3A9H1014157)
This publication has 54 references indexed in Scilit:
- Transport of drugs across the blood–brain barrier by nanoparticlesJournal of Controlled Release, 2012
- In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and sizeActa Biomaterialia, 2010
- ANS Binding Reveals Common Features of Cytotoxic Amyloid SpeciesACS Chemical Biology, 2010
- An impaired alveolar-capillary barrier in vitro : effect of proinflammatory cytokines and consequences on nanocarrier interactionJournal of The Royal Society Interface, 2009
- Biodegradable luminescent porous silicon nanoparticles for in vivo applicationsNature Materials, 2009
- A Century of Alzheimer's DiseaseScience, 2006
- Controlling β-Amyloid Oligomerization by the Use of Naphthalene SulfonatesJournal of Biological Chemistry, 2005
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992
- Biotin Transport Through the Blood‐Brain BarrierJournal of Neurochemistry, 1987
- The role of the liver in drug metabolismThe American Journal of Medicine, 1970